Papers

4

Total Citations

83

H-Index

4

About

Dr. Hongzhou Meng is a pioneering urologic surgeon whose research centers on advancing minimally invasive surgical techniques for prostate and kidney cancers. His most impactful work focuses on the development and clinical application of novel single-port robotic surgical systems, specifically the Shurui single-port (SR-SP) platform. Dr. Meng’s major contributions include demonstrating the safety and efficacy of this innovative system in radical prostatectomy and partial nephrectomy, as detailed in his 2023 papers (20 and 17 citations, respectively). These studies represent a significant step forward in reducing surgical trauma and improving patient recovery. He has also contributed to the evidence base for robotic-assisted surgery through comparative analyses of health-related quality of life outcomes following different prostatectomy approaches (12 citations). Earlier work on robotic-assisted urethra-sparing simple prostatectomy (34 citations) further showcases his commitment to refining surgical techniques to preserve function. Dr. Meng’s research is at the forefront of the transition from multi-port to single-port robotic surgery, positioning him as a key figure in the next generation of urologic oncology.

Research Focus

Key Achievements

4
H-Index
4
Papers
83
Total Citations
21
Avg Citations/Paper
🏆 Most Cited Paper
Robotic-assisted Urethra-sparing Simple Prostatectomy Via an Extraperitoneal Approach
34 citations · 2018
📈 Most Prolific Year: 2023 (2 Papers)
🤝 Key Collaborators: 25
🏛 Institutions: Zhejiang University, First Affiliated Hospital Zhejiang University

Top Papers

  1. 1
  2. 2
  3. 3
  4. 4

Key Collaborators

Contact & Links

Available for collaboration
Content generated · 13 days ago